{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:21:31Z","timestamp":1776298891069,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40360-018-0198-1","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:11:51Z","timestamp":1518480711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A case report of clonidine induced syncope: a review of central actions of an old cardiovascular drug"],"prefix":"10.1186","volume":"19","author":[{"given":"Alexander J.","family":"Sandweiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Spichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Rozich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"198_CR1","doi-asserted-by":"publisher","first-page":"852051","DOI":"10.1155\/2012\/852051","volume":"2012","author":"ML Givens","year":"2012","unstructured":"Givens ML. Toxic bradycardias in the critically ill poisoned patient. Emerg Med Int. 2012;2012:852051.","journal-title":"Emerg Med Int"},{"issue":"11","key":"198_CR2","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"By the American Geriatrics Society Beers Criteria Update Expert Panel","year":"2015","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227\u201346.","journal-title":"J Am Geriatr Soc"},{"issue":"425","key":"198_CR3","first-page":"864","volume":"66","author":"J Ng","year":"1967","unstructured":"Ng J, et al. Properties of catapres, a new hypotensive drug: a preliminary report. N Z Med J. 1967;66(425):864\u201370.","journal-title":"N Z Med J"},{"issue":"4","key":"198_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/j.1552-4604.1967.tb00051.x","volume":"7","author":"GM Simpson","year":"1967","unstructured":"Simpson GM, Kunz-Bartholini E, Watts TP. A preliminary evaluation of the sedative effects of catapres, a new antihypertensive agent, in chronic schizophrenic patients. J Clin Pharmacol J New Drugs. 1967;7(4):221\u20135.","journal-title":"J Clin Pharmacol J New Drugs"},{"issue":"3","key":"198_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5694\/j.1326-5377.1968.tb27492.x","volume":"1","author":"AJ Barnett","year":"1968","unstructured":"Barnett AJ, Cantor S. Observations on the hypotensive action of \u201cCatapre\u201d (ST 155) in man. Med J Aust. 1968;1(3):87\u201391.","journal-title":"Med J Aust"},{"issue":"1","key":"198_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.7326\/0003-4819-92-1-74","volume":"92","author":"J Lowenstein","year":"1980","unstructured":"Lowenstein J. Drugs five years later: clonidine. Ann Intern Med. 1980;92(1):74\u20137.","journal-title":"Ann Intern Med"},{"issue":"2","key":"198_CR7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0022-3565(25)28470-1","volume":"171","author":"A Scriabine","year":"1970","unstructured":"Scriabine A, et al. Cardiac slowing effects of clonidine (ST-155) in dogs. J Pharmacol Exp Ther. 1970;171(2):256\u201364.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2-3","key":"198_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0165-1838(98)00090-3","volume":"72","author":"GA Head","year":"1998","unstructured":"Head GA, Gundlach AL, Musgrave IF. Recent advances in imidazoline receptor research: ligands--localization and isolation--signaling--functional and clinical studies. J Auton Nerv Syst. 1998;72(2-3):74\u20139.","journal-title":"J Auton Nerv Syst"},{"issue":"7613","key":"198_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0140-6736(69)91423-8","volume":"2","author":"AL Muir","year":"1969","unstructured":"Muir AL, Burton JL, Lawrie DM. Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties. Lancet. 1969;2(7613):181\u20134.","journal-title":"Lancet"},{"key":"198_CR10","doi-asserted-by":"crossref","unstructured":"Shaw M, Matsa R. Clonidine withdrawal induced sympathetic surge. BMJ Case Rep. 2015;1-3.","DOI":"10.1136\/bcr-2015-210325"},{"issue":"4","key":"198_CR11","first-page":"399","volume":"41","author":"LL Golusinski Jr","year":"1995","unstructured":"Golusinski LL Jr. And B.W. Blount, Clonidine-induced bradycardia. J Fam Pract. 1995;41(4):399\u2013401.","journal-title":"J Fam Pract"},{"issue":"5","key":"198_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1042\/CS20050101","volume":"109","author":"NL Kanagy","year":"2005","unstructured":"Kanagy NL. Alpha(2)-adrenergic receptor signalling in hypertension. Clin Sci (Lond). 2005;109(5):431\u20137.","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"198_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/15563650.2016.1277234","volume":"55","author":"GK Isbister","year":"2017","unstructured":"Isbister GK, et al. Adult clonidine overdose: prolonged bradycardia and central nervous system depression, but not severe toxicity. Clin Toxicol (Phila). 2017;55(3):187\u201392.","journal-title":"Clin Toxicol (Phila)"},{"issue":"5","key":"198_CR14","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1152\/jn.00085.2002","volume":"88","author":"AR Granata","year":"2002","unstructured":"Granata AR, Cohen MI. Rhythmic properties of neurons in the rostral ventrolateral medulla of the rat in vitro: effects of clonidine. J Neurophysiol. 2002;88(5):2262\u201379.","journal-title":"J Neurophysiol"},{"issue":"1","key":"198_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0006-8993(86)91198-4","volume":"377","author":"AR Granata","year":"1986","unstructured":"Granata AR, et al. A1 noradrenergic neurons tonically inhibit sympathoexcitatory neurons of C1 area in rat brainstem. Brain Res. 1986;377(1):127\u201346.","journal-title":"Brain Res"},{"issue":"5 Pt 2","key":"198_CR16","first-page":"R1065","volume":"265","author":"AM Allen","year":"1993","unstructured":"Allen AM, Guyenet PG. Alpha 2-adrenoceptor-mediated inhibition of bulbospinal barosensitive cells of rat rostral medulla. Am J Phys. 1993;265(5 Pt 2):R1065\u201375.","journal-title":"Am J Phys"},{"issue":"1","key":"198_CR17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0022-3565(25)12477-4","volume":"253","author":"P Ernsberger","year":"1990","unstructured":"Ernsberger P, et al. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther. 1990;253(1):408\u201318.","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"198_CR18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/BF01935099","volume":"29","author":"H Schmitt","year":"1973","unstructured":"Schmitt H, Fenard S. Decrease in the sympatho-inhibitory action of clonidine after destruction of the sympatho-inhibitory area. Experientia. 1973;29(10):1247\u20139.","journal-title":"Experientia"},{"issue":"1","key":"198_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(87)90125-7","volume":"134","author":"P Ernsberger","year":"1987","unstructured":"Ernsberger P, et al. Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. Eur J Pharmacol. 1987;134(1):1\u201313.","journal-title":"Eur J Pharmacol"},{"issue":"1-2","key":"198_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.autneu.2003.08.011","volume":"109","author":"WZ Wang","year":"2003","unstructured":"Wang WZ, Yuan WJ, Su DF. Blockade of N-methyl-D-aspartate receptors within the rostral ventrolateral medulla antagonizes clonidine-induced cardiovascular effects. Auton Neurosci. 2003;109(1-2):21\u20138.","journal-title":"Auton Neurosci"},{"issue":"2","key":"198_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00221-004-1902-5","volume":"158","author":"WZ Wang","year":"2004","unstructured":"Wang WZ, et al. Interaction between clonidine and N-methyl-D-aspartate receptors in the caudal ventrolateral medulla of rats. Exp Brain Res. 2004;158(2):259\u201364.","journal-title":"Exp Brain Res"},{"key":"198_CR22","first-page":"155","volume":"14","author":"D Mendelowitz","year":"1999","unstructured":"Mendelowitz D. Advances in parasympathetic control of heart rate and cardiac function. News Physiol Sci. 1999;14:155\u201361.","journal-title":"News Physiol Sci"},{"issue":"2","key":"198_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0304-3940(91)90305-D","volume":"132","author":"D Mendelowitz","year":"1991","unstructured":"Mendelowitz D, Kunze DL. Identification and dissociation of cardiovascular neurons from the medulla for patch clamp analysis. Neurosci Lett. 1991;132(2):217\u201321.","journal-title":"Neurosci Lett"},{"issue":"1","key":"198_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1213\/ane.0b013e31818d8b79","volume":"108","author":"X Wang","year":"2009","unstructured":"Wang X. Propofol and isoflurane enhancement of tonic gamma-aminobutyric acid type a current in cardiac vagal neurons in the nucleus ambiguus. Anesth Analg. 2009;108(1):142\u20138.","journal-title":"Anesth Analg"},{"key":"198_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainres.2008.06.012","volume":"1224","author":"HS Jameson","year":"2008","unstructured":"Jameson HS, Pinol RA, Mendelowitz D. Purinergic P2X receptors facilitate inhibitory GABAergic and glycinergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Brain Res. 2008;1224:53\u201362.","journal-title":"Brain Res"},{"key":"198_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2010.06.001","volume":"1347","author":"KE Philbin","year":"2010","unstructured":"Philbin KE, Bateman RJ, Mendelowitz D. Clonidine, an alpha2-receptor agonist, diminishes GABAergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Brain Res. 2010;1347:65\u201370.","journal-title":"Brain Res"},{"issue":"1","key":"198_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1074248415587969","volume":"21","author":"MN McComb","year":"2016","unstructured":"McComb MN, Chao JY, Ng TM. Direct vasodilators and sympatholytic agents. J Cardiovasc Pharmacol Ther. 2016;21(1):3\u201319.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"2","key":"198_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/bja\/aet027","volume":"111","author":"Y Ginosar","year":"2013","unstructured":"Ginosar Y, Riley ET, Angst MS. Analgesic and sympatholytic effects of low-dose intrathecal clonidine compared with bupivacaine: a dose-response study in female volunteers. Br J Anaesth. 2013;111(2):256\u201363.","journal-title":"Br J Anaesth"},{"issue":"1","key":"198_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejpn.2015.10.002","volume":"20","author":"F Jiao","year":"2016","unstructured":"Jiao F, et al. Clinical observation on treatment of Tourette syndrome in Chinese children by clonidine adhesive patch. Eur J Paediatr Neurol. 2016;20(1):80\u20134.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"198_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3109\/00952990.2011.644003","volume":"38","author":"P Mannelli","year":"2012","unstructured":"Mannelli P, et al. The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal. Am J Drug Alcohol Abuse. 2012;38(3):200\u20135.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"198_CR31","first-page":"CD000058","volume":"3","author":"SG Gourlay","year":"2004","unstructured":"Gourlay SG, Stead LF, Benowitz NL. Clonidine for smoking cessation. Cochrane Database Syst Rev. 2004;3:CD000058.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-018-0198-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:07:20Z","timestamp":1751396840000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-018-0198-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1186\/s40360-018-0198-1","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"11 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from the patient to report individual data within the text and images for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"6"}}